MEMORIAL DAY OFFER 50% OFF Premium Subscription Order Now MEMORIAL DAY 50% OFF Subscription >>

No Pain, No Gain.Week 21 On Stock Market Click to watch.

$23.41 (4.56%)

Volume: 1.136M

Closed: May 27, 2022

Hollow Logo Score: 3.809

ChemoCentryx Stock Forecast

BUY SELL NASDAQ:CCXI
$23.41 (4.56%)

Volume: 1.136M

Closed: May 27, 2022

Score Hollow Logo 3.809

ChemoCentryx Stock Forecast NASDAQ:CCXI

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-06 352.8% Raymond James $110.00 $106.00 Maintains Strong Buy
2021-11-10 369.88% Raymond James $107.00 $110.00 Maintains Strong Buy
2021-10-11 62.32% JP Morgan $14.00 $38.00 Upgrades Underweight Neutral
2021-10-11 357.07% Raymond James $62.00 $107.00 Upgrades Outperform Strong Buy
2021-10-11 173.39% SVB Leerink $17.00 $64.00 Upgrades Market Perform Outperform
2021-10-08 357.07% Raymond James $62.00 $107.00 Upgrades Outperform Strong Buy
2021-07-07 32.42% Stifel $26.00 $31.00 Upgrades Hold Buy
2021-05-07 -27.38% SVB Leerink $84.00 $17.00 Downgrades Outperform Market Perform
2021-05-07 6.79% Piper Sandler $80.00 $25.00 Downgrades Overweight Neutral
2021-05-07 -27.38% JP Morgan $57.00 $17.00 Downgrades Neutral Underweight
2021-05-07 11.06% Stifel $93.00 $26.00 Downgrades Buy Hold
2021-05-07 117.86% Raymond James $120.00 $51.00 Downgrades Strong Buy Outperform
2021-05-07 19.61% HC Wainwright & Co. $101.00 $28.00 Maintains Buy
2021-03-02 412.6% Raymond James $119.00 $120.00 Maintains Strong Buy
2021-03-02 297.27% Stifel $93.00 Initiates Coverage On Buy
2021-01-08 408.33% Raymond James $100.00 $119.00 Maintains Strong Buy
2020-10-29 199.02% Wells Fargo $79.00 $70.00 Maintains Overweight
2020-10-29 258.82% SVB Leerink $75.00 $84.00 Maintains Outperform
2020-10-29 156.3% JP Morgan $63.00 $60.00 Downgrades Overweight Neutral
2020-10-29 203.29% Piper Sandler $67.00 $71.00 Maintains Overweight
2020-08-11 327.17% Raymond James $95.00 $100.00 Maintains Strong Buy
2020-07-29 160.57% JP Morgan $64.00 $61.00 Maintains Overweight
2020-06-17 199.02% BTIG $70.00 Initiates Coverage On Buy
2020-05-27 237.46% Wells Fargo $79.00 Initiates Coverage On Overweight
2020-05-19 147.76% Canaccord Genuity $68.00 $58.00 Maintains Buy
2020-05-14 173.39% JP Morgan $61.00 $64.00 Maintains Overweight
2020-05-12 190.47% Canaccord Genuity $64.00 $68.00 Maintains Buy
2020-05-12 335.71% Raymond James $38.00 $102.00 Reiterates Strong Buy
2020-05-12 177.66% SVB Leerink $54.00 $65.00 Reiterates Outperform
2020-03-11 160.57% JP Morgan $60.00 $61.00 Maintains Overweight
2020-03-11 173.39% Raymond James $56.00 $64.00 Maintains Strong Buy
2020-02-18 156.3% JP Morgan $28.00 $60.00 Maintains Overweight
2020-01-24 156.3% HC Wainwright & Co. $40.00 $60.00 Maintains Buy
2019-11-26 105.04% Canaccord Genuity $16.00 $48.00 Maintains Buy
2019-11-26 139.21% Raymond James $17.00 $56.00 Maintains Strong Buy
2019-09-12 -40.2% JP Morgan $16.00 $14.00 Upgrades Neutral Overweight
2019-06-06 -27.38% Raymond James $24.00 $17.00 Maintains Strong Buy

CCXI Stock Trend

Given the current short-term trend, the stock is expected to fall -23.97% during the next 3 months and, with a 90% probability hold a price between $10.43 and $17.80 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-06-01 $13.60 $18.45 $23.29
2022-06-02 $13.49 $18.33 $23.18
2022-06-03 $13.37 $18.21 $23.06
2022-06-06 $13.25 $18.10 $22.94
2022-06-07 $13.13 $17.98 $22.82
2022-06-08 $13.02 $17.86 $22.71
2022-06-09 $12.90 $17.74 $22.59
2022-06-10 $12.78 $17.63 $22.47
2022-06-13 $12.67 $17.51 $22.36
2022-06-14 $12.55 $17.39 $22.24
2022-06-15 $12.43 $17.28 $22.12
2022-06-16 $12.31 $17.16 $22.00
2022-06-17 $12.20 $17.04 $21.89
2022-06-21 $12.08 $16.92 $21.77
2022-06-22 $11.96 $16.81 $21.65
2022-06-23 $11.85 $16.69 $21.54
2022-06-24 $11.73 $16.57 $21.42
2022-06-27 $11.61 $16.46 $21.30
2022-06-28 $11.49 $16.34 $21.18
2022-06-29 $11.38 $16.22 $21.07
2022-06-30 $11.26 $16.10 $20.95
2022-07-01 $11.14 $15.99 $20.83
2022-07-05 $11.03 $15.87 $20.72
2022-07-06 $10.91 $15.75 $20.60
2022-07-07 $10.79 $15.64 $20.48
2022-07-08 $10.67 $15.52 $20.36
2022-07-11 $10.56 $15.40 $20.25
2022-07-12 $10.44 $15.28 $20.13
2022-07-13 $10.32 $15.17 $20.01
2022-07-14 $10.21 $15.05 $19.90

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and cancer in the United States. Its lead drug candidates in clinical development include CCX168, which is in Phase II clinical trials for the treatment of orphan and rare diseases; CCX872, which is in Phase I... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT